[Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): the challenge of a new consensus conference].
Chidiac
C
C
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019090:Case Management / Q000639:trends; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy*; D003245:Consensus Statements as Topic; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D006760:Hospitalization; D006801:Humans; D007121:Immunocompetence; D018410:Pneumonia, Bacterial / Q000150:complications / Q000188:drug therapy*; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications*; D018570:Risk Assessment; D012307:Risk Factors; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents